No Data
Changzhou Almaden (002623.SZ): Invested 14 million yuan to establish a holding subsidiary Inner Mongolia ERDOS Resources Almaden.
Gelonghui reported on December 20 that Changzhou Almaden (002623.SZ) announced the establishment of a joint venture with Shanghai Yuntian to set up Changzhou Almaden (Inner Mongolia ERDOS Resources) New Materials Co., Ltd. (hereinafter referred to as "Inner Mongolia Almaden"). The registered capital of Inner Mongolia Almaden is 20 million yuan, of which the company contributes 14 million yuan, accounting for 70% of the registered capital; Shanghai Yuntian contributes 6 million yuan, accounting for 30% of the registered capital. Changzhou Almaden (Inner Mongolia ERDOS Resources) New Materials Co., Ltd. is the company's implementation of its Global Strategy in the northern region.
Amaton: Third quarter report 2024
Changzhou Almaden (002623.SZ): a net loss of 26.6326 million yuan in the first three quarters.
Changzhou Almaden (002623.SZ) announced its third quarter report for 2024 on October 30th, with the company achieving revenue of 2.447 billion yuan in the first three quarters, a year-on-year decrease of 9.27%; net income attributable to shareholders of the listed company was -26.6326 million yuan; net income attributable to shareholders of the listed company excluding non-recurring items was -40.2771 million yuan; basic earnings per share was -0.14 yuan.
The Three-year Loss for Changzhou Almaden (SZSE:002623) Shareholders Likely Driven by Its Shrinking Earnings
Changzhou Almaden (002623.SZ): There is currently no involvement in the production and manufacturing business of raw glass, and there is no heavy alkali consumption.
Changzhou Almaden (002623.SZ) stated on the investor interaction platform on October 16 that the company is currently a glass deep processing enterprise, not involved in the production and manufacturing business of original glass, and does not have heavy alkali consumption.
October 10 A-share Lightning Rod: tianfeng Securities: the company has no plans for merger and reorganization; changzhou almaden: shareholder Lin Jinkun intends to reduce shareholding by no more than 1.24%.
Hengshi Ophthalmology's shareholders Meixin Fund and Pengxin Fund intend to collectively reduce their holdings by no more than 0.83 million shares; Almaden's shareholder Lin Jinkun intends to reduce his shareholding by no more than 1.24%; Guangdong Dcenti Auto-Parts Stock's shareholder Taifeng International intends to reduce its shareholding by no more than 1%; ST Baili is suspected of violating disclosure regulations, and the CSRC has decided to initiate a case against the company and its controlling shareholder Wang Hairong; CSI All Share Investment Banking & Tianfeng Securities Co., Ltd. is not planning a merger or reorganization; *ST Zhongrun has terminated the private placement of stocks for the year 2022.
Changzhou Almaden Co., Ltd.'s (SZSE:002623) Share Price Is Still Matching Investor Opinion Despite 29% Slump
